PLEASE NOTE : This is a development system.
For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.
For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.
You are here : Home > PAD Profile : Spironolactone - Oedema
PAD Profile : Spironolactone - Oedema
Keywords :
potassium sparing diuretics, aldosterone antagonists
Brand Names Include :
Aldactone
Traffic Light Status
Status 1 of 1.
Guidelines
No guidelines returned.
Other Drugs
- Furosemide
- Bumetanide
- Bendroflumethiazide
- Amiloride hydrochloride
- Co-amilofruse (Amiloride hydrochloride/frusemide)
- Metolazone
Other Indications
Additional Documents
No additional documents returned.
Committee Recommendations
Date
Committee Name
Narrative
03 May 2017
Surrey & North West Sussex Area Prescribing Committee (formerly Prescribing Clinical Network)
GENERIC Spironolactone has been considered by the PCN and has been assigned a GREEN traffic light status.
NOTE - the branded product, Aldactone, was considered BLACK at the PCN in May 2017.
01 April 2015
Surrey & North West Sussex Area Prescribing Committee (formerly Prescribing Clinical Network)
This drug has been agreed as appropriate for initiation in Primary Care and/or continued in Primary Care following a recommendation from specialists in other health care sectors. Following consideration by the PCN, it has been assigned a GREEN traffic light status.
Associated BNF Codes
02. Cardiovascular System
02.02.03. Potassium-sparing diuretics and aldosterone antagonists